Back

Prasugrel over ticagrelor in non-ST-elevation acute coronary syndromes: is it justified?

European Heart Journal

17 November 2020
Organised by: Logo
Read full article
ESC Journals CARDIOVASCULAR PHARMACOLOGY CORONARY ARTERY DISEASE, ACUTE CORONARY SYNDROMES, ACUTE CARDIAC CARE Acute Coronary Syndromes Interventional Cardiology Pharmacology and Pharmacotherapy
You may be interested in
thumbnail
Congress Presentation
Ticagrelor or prasugrel in patients with acute coronary syndrome and high bleeding risk
27 August 2022
thumbnail
Webinar
The EAPCI Journal Club: T-PASS Randomised Trial
14 November 2023
thumbnail
ESC Journals
Cohort profile: the ESC EURObservational Research Programme Non-ST-segment elevation myocardial infraction (NSTEMI) Registry
19 October 2022
thumbnail
Congress Presentation
Cost-effectiveness of clopidogrel versus ticagrelor in patients of 70 years or older with non-ST-elevation acute coronary syndrome
27 August 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources